Posts
August 13 2012
Eco Building Products, Inc. announced the closing of their PIPE offering in the amount of $1,080,000. EG&S acted as counsel to the Investor.
August 08 2012
ARCA biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $952,710. EG&S acted as counsel to the placement agent.
August 07 2012
pSivida Corp. announced the closing of their Registered Direct offering in the amount of $5,363,000. EG&S acted as counsel to the placement agent.
August 06 2012
Stevia Corp. announced the closing of their PIPE offering in the amount of $500,000. EG&S acted as counsel to the Investor.
July 31 2012
NutraCea announced the closing of their PIPE offering in the amount of $290,000. EG&S acted as counsel to the Investor.
July 26 2012
Infinity Cross Border AcquisitionCorporation (Nasdaq: INXBU) announced the closing of their SPAC IPO in the amount of $40,000,000. EG&S acted as counsel to Infinity.
July 20 2012
Saul H. Finkelstein, a member of the Firm, participated in a webinar on M&A Confidentiality Agreements. The panel reviewed the latest developments with non-disclosure agreements, examined key elements of the agreement, and offered negotiation approaches for sellers and buyers.
July 20 2012
Brianstorm Cell Therapeutics, Inc. announced the closing of their Registered Direct offering in the amount of $972,500. EG&S acted as counsel to the placement agent.